Drug Information

Drug General Information
Drug ID
D04XEQ
Former ID
DNCL002542
Drug Name
Imetelstat
Drug Type
Small molecular drug
Indication Essential thrombocythemia; Late-stage non-small cell lung cancer; Metastatic breast cancer; Multiple myeloma [ICD9: 238.71, 289.9, 162, 203.0, 208.9, 203; ICD10:D47.3, D75.2, D75.8, C33-C34, C50, C90] Phase 2 [525169]
Company
Geron
Structure
Download
2D MOL
Formula
C22H29N5O9P2
PubChem Compound ID
16097729
References
Ref 525169ClinicalTrials.gov (NCT02426086) Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.